Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.
Press releases published on September 17, 2025
The Association of American Physicians and Surgeons (AAPS) Supports HHS Secretary Kennedy and Making America Healthy Again (MAHA)
TUCSON, Ariz., Sept. 17, 2025 (GLOBE NEWSWIRE) -- On September 13, at its 82nd annual meeting in Chantilly, VA, the Association of American Physicians and Surgeons (AAPS) passed the following emergency resolution, which was authored by Wayne Iverson, M.D.: …
Thirty Inspiring Middle School Scientists and Engineers Shine as Finalists in the Thermo Fisher Scientific Junior Innovators Challenge
WASHINGTON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Society for Science today announced the 30 finalists in the Thermo Fisher Scientific Junior Innovators Challenge (Thermo Fisher JIC), the nation’s premier middle school science, technology, engineering and …
FMOL Health Shows Drastic Reduction in Sepsis Related Deaths
Baton Rouge, LA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- In alignment with Sepsis Awareness Month, members of the media are invited to attend a virtual press conference to learn more about sepsis and the latest in life-saving care. Our panel of subject experts …
Joint Commission and Kaiser Permanente Recognize Cone Health with 2025 Bernard J. Tyson Award for Pursuit of Healthcare Equity
WASHINGTON, D.C., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Joint Commission and Kaiser Permanente today announced Cone Health as the recipient of the 2025 Bernard J. Tyson Award for Pursuit of Healthcare Equity. This prestigious award, established in honor of …
2025 Buyer’s Guide - Best Lion’s Mane Supplement — deep research, how it works, benefits, safety, and product picks why MushCanyon
washington DC, Sept. 17, 2025 (GLOBE NEWSWIRE) -- MushCanyon today unveils the 2025 Buyer’s Guide: Best Lion’s Mane Supplement—a research-driven resource that demystifies how Lion’s Mane works, its cognitive and mood benefits, safety profile, and what to …
Foundation for Sarcoidosis Research Reacts to the Announcement of aTyr Pharma’s Phase 3 Clinical Trial Results
CHICAGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) expresses both solidarity and resolve as aTyr Pharma announced that its Phase 3 trial of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint but …
Young Innovations Announces Distribution Partnership with OrthoNu® to Expand Its Specialty Orthodontic Care Product Offering
Algonquin, IL, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Young Innovations, Inc. (“Young”), a leading global manufacturer and distributor of dental products, is pleased to announce a new strategic partnership with OrthoNu®, an innovator in orthodontic self-care …
At CPHI Frankfurt, TekniPlex Healthcare to Present Full Range of Barrier Blister Films, Customized Liquid Drug Delivery Solutions and Live Demonstrations of Latest Filling-Sealing Machine
Wayne, PA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, will spotlight its extensive portfolio of barrier blister films at CPHI Frankfurt, October 28- …
Mapi Pharma Announces First Patient Recruited in Phase-I/II Study of Cariprazine Depot Once Monthly Injection
NESS ZIONA, Israel, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a fully integrated, late-stage clinical development biopharmaceutical company focused on developing innovative long-acting depot injectable treatments, today provided an update on the …
Acentra Health Named one of the ‘Fastest Growing Companies’ by the Washington Business Journal
MCLEAN, Va., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to helping government and commercial healthcare clients and the populations they serve, has been named to the Washington …
Results from Phase 2 COURAGE Trial Demonstrating Potential to Improve Quality of GLP-1 receptor agonist-induced Weight Loss by Preserving Lean Mass, Presented at EASD
Complete 26-week results further demonstrate that combining semaglutide with trevogrumab (anti-GDF8/anti-myostatin) helped prevent about half of semaglutide-induced loss of lean mass, while increasing fat mass loss Numeric improvements in metabolic and …
New Study Highlights the Potential of Hyperbaric Oxygen Therapy as a Biologically Based Treatment for Long-Term PTSD Symptom Improvement
ORLANDO, Fla., Sept. 17, 2025 (GLOBE NEWSWIRE) -- It is estimated that more than 13 million Americans struggle with post-traumatic stress disorder (PTSD). A new study, Hyperbaric Oxygen Therapy for PTSD: Threshold Effect for Sustained Symptom Improvement …
24/7 Market News: Kraig Labs Spider Silk is Sustainable Alternative to Petroleum-Derived Plastics
DENVER, Sept. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, today spotlights a major environmental threat that Kraig Biocraft Laboratories (OTCQB: …
Synergy CHC Corp. (NASDAQ: SNYR) Partners with AlaBev to Launch FOCUSfactor® Beverages in 5,000+ Retail Outlets Across Alabama
WESTBROOK, Maine, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, today announced a strategic distribution partnership with AlaBev, one of the Southeast’s premier beverage distributors, …
Nylon flexTAP®: First FDA cleared 3D-Printed Midline Oral Appliance for Sleep Apnea
DALLAS, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Airway Management proudly announces a historic milestone with the FDA clearance of Nylon flexTAP®, the world’s first digitally printed single-point midline oral appliance device for sleep apnea. Launched today, …
Palisade Bio Reports Positive PALI-2108 Phase 1b Clinical Data
PALI-2108 demonstrated favorable safety, with no serious adverse events, lab abnormalities, or EKG concerns Phase 1b data demonstrated 100% clinical response and promising signals regarding the efficacy of PALI-2108 in ulcerative colitis (UC) using FDA- …
ACGME-I Announces Recipients of the 2026 ACGME International Awards
Chicago, Illinois, US, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ACGME International (ACGME-I) proudly announces the winners of the 2026 ACGME International Awards. These awards celebrate individuals who have shown extraordinary dedication to graduate medical …
ADARx Pharmaceuticals Appoints Industry Veteran, Laura Shawver, Ph.D., as Board Chair
– Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of their innovations – SAN DIEGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late- …
NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The world’s first therapeutic drug to be equipped with NovalGen’s pioneering AutoRegulation (AR) technology has been approved for evaluation in the clinic by the UK’s Medicine and Healthcare Products Regulatory …
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
EMERYVILLE, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA) (“XOMA Royalty” or the “Company”), a biotechnology royalty aggregator playing a distinctive role in helping biotech companies achieve their goal of improving …